William Weldon is Chairman and Chief Executive Officer of Johnson & Johnson and is the sixth Chairman in Johnson & Johnson's over one-hundred year history.
Weldon joined J&J as a sales representative for the McNeil Pharameutical division in 1971 and eventually became the head of J&J's Ethicon Endo-Surgery business in 1992. He became the head of J&J's pharmaceutical operations in 1998 and then became J&J's CEO in 2002. As CEO, Weldon engineered some of the largest acquisitions in J&J's history including the purchase of ALZA and Pfizer's consumer-health product line.
William Weldon received a BA in Biology from Quinnipiac University.
You could go to universal healthcare, and what that's going to do is bring about 47 million more people who are uninsured or underinsured into the market place, and that's a huge benefit to us. The government will negotiate price and the prices will come down, and that you could say is a disadvanta...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login
